AUG 7·SEC EDGARLow
Thakral Anshul sold $2.0M of FTRE
Thakral Anshul (Chief Executive Officer) sold 111,857 shares of Fortrea Holdings Inc. (FTRE) at an average of $18.12 ($18.06–$18.17, $2.03M total) across 2 trades on 2026-08-06.
StockNASDAQ · US · USDHealthcare · Biotechnology
$FTRE
Fortrea Holdings Inc.
Price · $FTREvia TradingView
AI sentiment · 7d1 articles
- Bullish
- 1
- Neutral
- 0
- Bearish
- 0
Top stories · $FTREMore →
AUG 6·SEC EDGAR
Thakral Anshul sold $1.9M of FTRE
Thakral Anshul (Chief Executive Officer) sold 99,869 shares of Fortrea Holdings Inc. (FTRE) at an average of $19.16 ($19.03–$19.28, $1.91M total) across 2 trades on 2026-08-05.
AUG 5·SEC EDGAR
SANDERS MACHELLE sold $175K of FTRE
SANDERS MACHELLE sold 9,700 shares of Fortrea Holdings Inc. (FTRE) at $18.01 ($0.17M total) on 2026-08-03.
FTRE sentiment & insider activity
Over the past 7 days, alphai's AI scored 1 news story mentioning FTRE (Fortrea Holdings Inc.). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.
Recent FTRE coverage spans earnings, insider activity and sector analysis.
In the last 30 days, FTRE insiders filed 5 SEC Form 4 transactions — no purchases and 5 sales ($4.1M). The most active reporter was Thakral Anshul, Chief Executive Officer, with 4 filings.
What's driving FTRE
This is a routine insider sale with no 10b5-1 plan disclosed, but it does not provide new operating or guidance information.
The filing discloses an insider sale by the CEO, which can modestly affect sentiment but does not change fundamentals by itself.
A routine insider open-market sale on a Form 4 provides limited incremental signal, but can slightly affect near-term sentiment.
FTRE is positioned as improving fundamentals via contract demand, AI-enabled trial solutions, and forecast raises.
Guidance raise plus improving cash flow and cost savings are likely to support near-term sentiment, while CFO transition risk may add uncertainty.
alphai scores every news story that mentions FTRE with an AI model for sentiment and relevance, and aggregates insider trades from Fortrea Holdings Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $FTRE
Score
Thakral Anshul sold $2.0M of FTRE
Thakral Anshul (Chief Executive Officer) sold 111,857 shares of Fortrea Holdings Inc. (FTRE) at an average of $18.12 ($18.06–$18.17, $2.03M total) across 2 trades on 2026-08-06.
2 min readThakral Anshul sold $1.9M of FTRE
Thakral Anshul (Chief Executive Officer) sold 99,869 shares of Fortrea Holdings Inc. (FTRE) at an average of $19.16 ($19.03–$19.28, $1.91M total) across 2 trades on 2026-08-05.
2 min readSANDERS MACHELLE sold $175K of FTRE
SANDERS MACHELLE sold 9,700 shares of Fortrea Holdings Inc. (FTRE) at $18.01 ($0.17M total) on 2026-08-03.
2 min readMarkets: Three stocks analysts are chasing as the AI rally cools
The article says investors are rotating from highly valued AI infrastructure toward healthcare, citing a Bank of America survey and recent sector performance. It highlights three healthcare stocks: Aurinia Pharmaceuticals (AUPH) with Q1 revenue $77.7M and EPS $0.25; Fortrea (FTRE) raising full-year sales and adjusted EBITDA; and Aveanna (AVAH) after a $175.5M acquisition, guiding FY revenue $2.63B-$2.65B.
6 min readFortrea Q2 Earnings Call Highlights
"The environment has become more supportive, but our results are not simply the result of market recovery," Thakral said, attributing the performance to changes in commercial execution, including improved global coordination, a sharper focus on opportunities where the company can compete effectively and a clearer approach to serving distinct customer segments. Thakral said Fortrea's clinical pharmacology services business was a particular area of strength.
6 min read
Fortrea (NASDAQ:FTRE) Reports Strong Q2 CY2026, Full
Fortrea Holdings (NASDAQ:FTRE) reported Q2 CY2026 revenue of $678.2 million, down 4.5% year over year but 4.7% above market expectations, according to the company. Full-year revenue guidance was $2.66 billion at the midpoint, 1.8% above analysts’ estimates. Non-GAAP EPS was $0.23, 27.2% above consensus.
4 min readFortrea Holdings Inc: Fortrea Reports Second Quarter 2026 Results
Fortrea (Nasdaq: FTRE) reported Q2 2026 revenue of $678.2 million, down from $710.3 million a year earlier. GAAP net loss was $13.2 million, while adjusted net income was $22.7 million and adjusted EBITDA $58.7 million. Book-to-bill was 1.06x and backlog $7.8 billion. Full-year guidance was raised to $2.62B-$2.69B revenue and $205M-$220M adjusted EBITDA.
3 min readFortrea Holdings Inc. (FTRE): Results of Operations and Financial Condition
Fortrea Holdings Inc. (FTRE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991-pressreleasedat.htm EX-99.1 Document Exhibit 99.1 Fortrea Reports Second Quarter 2026 Results Four consecutive quarters of execution to drive commercial, operational and financial excellence Increases full-year guidance Highlights For the three months ended J
4 min read
Fortrea Earnings: What To Look For From FTRE
Fortrea Holdings (FTRE) is set to report earnings Wednesday. Last quarter it posted revenue of $636.5M, down 2.3% YoY, and beat analysts on EPS and full-year EBITDA guidance. This quarter, analysts expect revenue down 8.8% YoY. FTRE is up 9.2% over a month; average analyst price target is $17.25 versus $19.13.
3 min readFortrea Holdings Inc. (FTRE): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Fortrea Holdings Inc. (FTRE) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. ftre-20260708 0001965040 FALSE 0001965040 2026-07-08 2026-07-08 0001965040 us-gaap:CommonClassAMember 2026-07-08 2026-07-08 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE A
3 min read